Wenwen Chien

2.1k total citations
29 papers, 1.1k citations indexed

About

Wenwen Chien is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Wenwen Chien has authored 29 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Molecular Biology, 8 papers in Oncology and 4 papers in Cancer Research. Recurrent topics in Wenwen Chien's work include Epigenetics and DNA Methylation (4 papers), Ubiquitin and proteasome pathways (4 papers) and Endoplasmic Reticulum Stress and Disease (3 papers). Wenwen Chien is often cited by papers focused on Epigenetics and DNA Methylation (4 papers), Ubiquitin and proteasome pathways (4 papers) and Endoplasmic Reticulum Stress and Disease (3 papers). Wenwen Chien collaborates with scholars based in United States, Singapore and Japan. Wenwen Chien's co-authors include H. Phillip Koeffler, Lin Pei, Ling‐Wen Ding, Carl W. Miller, Qiao‐Yang Sun, Jonathan Said, Ngan Doan, Manoj Garg, Norihiko Kawamata and Sigal Gery and has published in prestigious journals such as Journal of Biological Chemistry, Blood and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

Wenwen Chien

28 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Wenwen Chien United States 20 822 250 212 161 120 29 1.1k
Nicholas Davies United Kingdom 15 584 0.7× 298 1.2× 117 0.6× 191 1.2× 104 0.9× 25 1000
Gregory Dyson United States 20 577 0.7× 304 1.2× 326 1.5× 98 0.6× 160 1.3× 74 1.1k
Masamitsu Onda Japan 21 730 0.9× 341 1.4× 186 0.9× 192 1.2× 96 0.8× 43 1.2k
Taiji Yamazoe Japan 13 546 0.7× 437 1.7× 231 1.1× 115 0.7× 115 1.0× 26 1.0k
Hugues Ripoche France 14 653 0.8× 226 0.9× 307 1.4× 89 0.6× 44 0.4× 20 992
Carmela De Marco Italy 20 691 0.8× 336 1.3× 242 1.1× 60 0.4× 72 0.6× 34 1000
Wendy Prime United Kingdom 17 662 0.8× 358 1.4× 279 1.3× 75 0.5× 53 0.4× 24 1.1k
Gloria Manzotti Italy 14 612 0.7× 221 0.9× 255 1.2× 52 0.3× 162 1.4× 31 918
Eftihia Cocolakis Canada 12 898 1.1× 342 1.4× 120 0.6× 69 0.4× 49 0.4× 20 1.2k
Catherine D. Moser United States 17 701 0.9× 182 0.7× 188 0.9× 275 1.7× 233 1.9× 36 1.2k

Countries citing papers authored by Wenwen Chien

Since Specialization
Citations

This map shows the geographic impact of Wenwen Chien's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wenwen Chien with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wenwen Chien more than expected).

Fields of papers citing papers by Wenwen Chien

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wenwen Chien. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wenwen Chien. The network helps show where Wenwen Chien may publish in the future.

Co-authorship network of co-authors of Wenwen Chien

This figure shows the co-authorship network connecting the top 25 collaborators of Wenwen Chien. A scholar is included among the top collaborators of Wenwen Chien based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wenwen Chien. Wenwen Chien is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zheng, Yueyuan, Wenwen Chien, Sandrine Billet, et al.. (2023). ARID1A Deficiency Regulates Anti-Tumor Immune Response in Esophageal Adenocarcinoma. Cancers. 15(22). 5377–5377. 3 indexed citations
2.
Chien, Wenwen, Jeffrey Tyner, Sigal Gery, et al.. (2023). Treatment for ovarian clear cell carcinoma with combined inhibition of WEE1 and ATR. Journal of Ovarian Research. 16(1). 80–80. 5 indexed citations
3.
Sun, Qiao‐Yang, Ling‐Wen Ding, Kara Johnson, et al.. (2019). SOX7 regulates MAPK/ERK-BIM mediated apoptosis in cancer cells. Oncogene. 38(34). 6196–6210. 38 indexed citations
4.
Chien, Wenwen, Makoto Sudo, Ling‐Wen Ding, et al.. (2018). Functional Genome-wide Screening Identifies Targets and Pathways Sensitizing Pancreatic Cancer Cells to Dasatinib. Journal of Cancer. 9(24). 4762–4773. 28 indexed citations
5.
Mayer, Roger C., et al.. (2018). Strategies Taxicab Owners Use to Sustain Their Operations in a Competitive Environment. ScholarWorks (Walden University). 1 indexed citations
6.
Ding, Ling‐Wen, Qiao‐Yang Sun, Wenwen Chien, et al.. (2018). Profiling the B/T cell receptor repertoire of lymphocyte derived cell lines. BMC Cancer. 18(1). 940–940. 8 indexed citations
7.
Takao, Sumiko, Wenwen Chien, Vikas Madan, et al.. (2017). Targeting the vulnerability to NAD+ depletion in B-cell acute lymphoblastic leukemia. Leukemia. 32(3). 616–625. 30 indexed citations
8.
Ding, Ling‐Wen, Takayuki Ikezoe, M Mori, et al.. (2016). Mutational profiling of a MonoMAC syndrome family with GATA2 deficiency. Leukemia. 31(1). 244–245. 24 indexed citations
9.
Ding, Ling‐Wen, Qiao‐Yang Sun, Anand Mayakonda, et al.. (2016). Mutational Profiling of Acute Lymphoblastic Leukemia with Testicular Relapse. Blood. 128(22). 2809–2809.
10.
Chien, Wenwen, Qiao‐Yang Sun, Kian Leong Lee, et al.. (2015). Activation of protein phosphatase 2A tumor suppressor as potential treatment of pancreatic cancer. Molecular Oncology. 9(4). 889–905. 57 indexed citations
11.
Ding, Ling‐Wen, Qiao‐Yang Sun, Wenwen Chien, et al.. (2014). LNK (SH2B3): paradoxical effects in ovarian cancer. Oncogene. 34(11). 1463–1474. 20 indexed citations
12.
Garg, Manoj, Deepika Kanojia, Ryoko Okamoto, et al.. (2014). Abstract 5570: Laminin-5 gamma-2 (LAMC2) is highly expressed in anaplastic thyroid carcinoma and is associated with tumor progression, migration and invasion by modulating signaling of EGFR. Cancer Research. 74(19_Supplement). 5570–5570. 1 indexed citations
13.
Chien, Wenwen, Ling‐Wen Ding, Qiao‐Yang Sun, et al.. (2014). Selective inhibition of unfolded protein response induces apoptosis in pancreatic cancer cells. Oncotarget. 5(13). 4881–4894. 71 indexed citations
14.
Sun, Haibo, Norimichi Hattori, Wenwen Chien, et al.. (2014). KPT-330 has antitumour activity against non-small cell lung cancer. British Journal of Cancer. 111(2). 281–291. 53 indexed citations
15.
Hayano, Takahide, Manoj Garg, Dong Yin, et al.. (2013). SOX7 is down-regulated in lung cancer. Journal of Experimental & Clinical Cancer Research. 32(1). 17–17. 61 indexed citations
16.
Chien, Wenwen, Kian Leong Lee, Qiao‐Yang Sun, et al.. (2013). Abstract 1291: Identification of penfluridol as potential treatment for pancreatic cancer cells.. Cancer Research. 73(8_Supplement). 1291–1291. 1 indexed citations
17.
Garg, Manoj, Deepika Kanojia, Ryoko Okamoto, et al.. (2013). Laminin-5γ-2 (LAMC2) Is Highly Expressed in Anaplastic Thyroid Carcinoma and Is Associated With Tumor Progression, Migration, and Invasion by Modulating Signaling of EGFR. The Journal of Clinical Endocrinology & Metabolism. 99(1). E62–E72. 64 indexed citations
18.
Chien, Wenwen. (2011). Expression of connective tissue growth factor (CTGF/CCN2) in breast cancer cells is associated with increased migration and angiogenesis. International Journal of Oncology. 38(6). 1741–7. 62 indexed citations
19.
Chien, Wenwen, T. Kumagai, Carl W. Miller, et al.. (2004). Cyr61 Suppresses Growth of Human Endometrial Cancer Cells. Journal of Biological Chemistry. 279(51). 53087–53096. 88 indexed citations
20.
Chien, Wenwen & Lin Pei. (2000). A Novel Binding Factor Facilitates Nuclear Translocation and Transcriptional Activation Function of the Pituitary Tumor-transforming Gene Product. Journal of Biological Chemistry. 275(25). 19422–19427. 97 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Nicholas Davies Breakdown of academic impact, for papers by Gregory Dyson Breakdown of academic impact, for papers by Masamitsu Onda Breakdown of academic impact, for papers by Taiji Yamazoe Breakdown of academic impact, for papers by Hugues Ripoche Breakdown of academic impact, for papers by Carmela De Marco Breakdown of academic impact, for papers by Wendy Prime Breakdown of academic impact, for papers by Gloria Manzotti Breakdown of academic impact, for papers by Eftihia Cocolakis Breakdown of academic impact, for papers by Catherine D. Moser
Rankless by CCL
2026